Cipla
Break Gilead’s patent since US has bought all stock of Remdesivir
Trump is trying to improve his waning electoral chances by reserving all of Gilead’s stock of Remdesivir to cover up his disastrous handling of the Covid-19 epidemic so far
US Buys Up Remdesivir: We Must Break Patents for Access to COVID-19 Drug
Newsclick’s Prabir Purkayastha discusses the US buying out supplies of the COVID-19 drug, Remdesivir.
- Brazil approves end to 6×1 work schedule and reduction of the work week to 40 hours
- Israel kills 31 people in Lebanon on the eve of Eid al-Adha
- Israel carries out sixth consecutive Eid massacre in Gaza
- Far-right Janez Janša to return for fourth government term in Slovenia
- With peace deal nearly final, US launches fresh attacks on Iran
